Skip to content

Clinical trials

Phase 3 Digestive System Diseases trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Digestive System Diseases Phase: Phase 3 Country / region: United Kingdom Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20122
20141
20191
20202
20243
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Active, not recruiting4
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
89bio, Inc.2
Mirum Pharmaceuticals, Inc.2
Celgene1
Furiex Pharmaceuticals, Inc1
Gilead Sciences1
Pfizer1
Rezolute1
Vertex Pharmaceuticals Incorporated1
Vir Biotechnology, Inc.1
Zealand Pharma1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Digestive System Diseases12
Liver Diseases6
Fibrosis3
Gastrointestinal Diseases3
Intestinal Diseases3
Metabolic Diseases3
Pancreatic Diseases3
Bile Duct Diseases2
Biliary Tract Diseases2
Cholestasis2

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.